Tag Archives: Alopecia

Alopecia

  • Alopecia Awareness Week

    Alopecia Awareness Week

    Alopecia Awareness Week: How wigs can help children with the condition feel more confident STELLA Hammet was five years old when her hair started falling out. The 12-year-old from Melbourne has alopecia, a rare auto-immune disease where the body’s immune system attacks the hair follicles. There is no cure and most sufferers are diagnosed before […]

  • alopecia report

    Asia Pacific Alopecia Treatment Market

    Asia Pacific Alopecia Treatment Market to Reach US$ 2,655.9 Mn by 2024, Driven by Increasing Prevalence of Chemotherapy Induced Alopecia By PMR According to a latest market report published by Persistence Market Research, titled “Asia Pacific Alopecia Treatment Market 🙁 2016-2024)”, revenue from the Asia Pacific alopecia treatment market is expected to expand at a […]

  • Alopecia

    Alopecia Market Projected to be 11.8 Billion By 2024

    Alopecia Market Projected to be Worth $11.8 Billion By 2024 The global alopecia market was valued at over USD 7.3 billion in 2015. Key factors attributing to the growth of the alopecia market include the increasing prevalence of various chronic diseases such as arthritis, depression, PCOS, diabetes mellitus, hypertension, and cancer, easy access to scalp […]

  • alopecia trial

    New Treatment for Alopecia Areata

    Concert Pharmaceuticals Initiates Phase 1 Trial of CTP-543 as a New Treatment for Alopecia Areata Concert Pharmaceuticals, Inc today announced that it has initiated its Phase 1 clinical program for CTP-543, which is being developed for the treatment of alopecia areata, an autoimmune disease for which there are currently no approved treatments. CTP-543 was discovered […]

  • market research alopecia

    Alopecia Clinical Review

    Alopecia Clinical Review, Market Growth, Segment, Trends and Forecast 2016 – 2020 “Alopecia Worldwide 2016 Clinical Trials Review, H2″ includes an complete overview of Alopecia scenario. This Alopecia report provides data relating on Alopecia clinical trials scenario across globe. Alopecia report also includes an review of trial numbers and also their ( Alopecia ) average […]

  • CTP-543 alopecia

    CTP-543 for Treatment of Alopecia Areata

    Concert Pharmaceuticals Unveils CTP-543 for Treatment of Alopecia Areata Concert Pharmaceuticals, Inc today announced its next product candidate, CTP-543, for the treatment of alopecia areata. Alopecia areata is an autoimmune disease characterized by patchy or widespread hair loss, for which there is significant unmet medical need and currently no FDA-approved treatment. CTP-543 is a deuterium-modified […]

  • Simvastatin/Ezetimibe Not Beneficial in Alopecia Areata

    Simvastatin/Ezetimibe Not Beneficial in Alopecia Areata

    Simvastatin/Ezetimibe Not Beneficial in Alopecia Areata Simvastatin/ezetimibe does not appear to be beneficial for severe alopecia areata (AA) in a sample of 20 patients, according to a letter to the editor published in the May issue of the Journal of the American Academy of Dermatology. Camilla Loi, M.D., from the University of Bologna in Italy, […]

  • alopecia report

    Alopecia Treatment Market

    Alopecia (Hair Loss)Treatment Market: Global Industry Analysis and Forecast 2016 – 2022 Alopecia is a term used to describe excessive hair damage under certain medical conditions or dietary issues. Sedentary lifestyle, and unhealthy diets is leading to loss of hair among masses. Furthermore, ageing and hormonal imbalance, increasing chronic disease like arthritis, cancer, hypertension, depression […]

  • Europe Alopecia Areata Market Highlights 2015

    Europe Alopecia Areata Market Highlights 2015

    Europe Alopecia Areata Market Highlights 2015 Research and Markets has announced the addition of the “Europe Alopecia Areata Market Highlights – 2015” report to their offering. The research helps executives track competitor drugs sales and market share in Europe alopecia areata market. It supports decision making in R&D to long term marketing strategies. The report […]

  • Samumed-hair loss trial

    Samumed Phase II Study For A Potential Treatment Of Alopecia

    Samumed Announces Increases In Both Hair Count And Hair Density Observed In Its Phase II Study For A Potential Treatment Of Androgenetic Alopecia (AGA) Samumed, LLC, a leader in tissue regeneration, announced today preliminary analysis of efficacy data from its Phase II AGA trial, in which one of the dosage arms, compared to vehicle, showed […]

  • pharma_report-alopecia

    Alopecia Global Clinical Trials Review, H1, 2015

      Recent research into the alopecia global clinical trials review for 2015 examined in new market research report Clinical trial report, “Alopecia Global Clinical Trials Review, H1, 2015″ provides an overview of Alopecia clinical trials scenario. This report provides top line data relating to the clinical trials on Alopecia. Report includes an overview of trial […]

  • Kerastem Alopecia

    Kerastem Receives Conditional Approval from FDA for Alopecia Trial

    Kerastem Technologies announce that the Company has received notice of conditional approval from the U.S. FDA Center For Biologics Evaluation and Research (CBER) Office of Cellular, Tissue and Gene Therapies to conduct a clinical trial investigating the safety and feasibility of the Company’s technology for the treatment of female and early male pattern baldness (androgenic […]